Funder
National Institute of General Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Gordois A, Pezzullo L, Cutler H (2010) The Global Economic Cost of Visual Impairment. Access Economics Pty Limited for AMD Alliance International
2. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106–116. https://doi.org/10.1016/S2214-109X(13)70145-1
3. Global $10.4 Bn Wet Age-Related Macular Degeneration Market to 2024— Rising Prevalence of AMD, Lack of a Specific Treatment, and Increasing Aging Population (2019). GlobeNewswire, 2019/05/15
4. Hutton-Smith LA, Gaffney EA, Byrne HM, Maini PK, Schwab D, Mazer NA (2016) A Mechanistic model of the intravitreal pharmacokinetics of large molecules and the pharmacodynamic suppression of ocular vascular endothelial growth factor levels by ranibizumab in patients with neovascular age-related macular degeneration. Mol Pharm 13(9):2941–2950. https://doi.org/10.1021/acs.molpharmaceut.5b00849
5. Hutton-Smith LA, Gaffney EA, Byrne HM, Maini PK, Gadkar K, Mazer NA (2017) Ocular pharmacokinetics of therapeutic antibodies given by intravitreal injection: estimation of retinal permeabilities using a 3-compartment semi-mechanistic model. Mol Pharm 14(8):2690–2696. https://doi.org/10.1021/acs.molpharmaceut.7b00164
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献